gmp platform biologics bioreactor sartorius production pipeline synthon end cell culture scale biotech core

Integrating Single-Use Systems in Pharma Manufacturing ...

Integrating Single-Use Systems in Pharma Manufacturing ...

Replace Paper with Productivity - Innovative Approach to Electronic Batch Records. The MODA-ES TM Electronic Batch Record Execution Platform is a comprehensive solution that bridges the gap that currently exists between manufacturing and QC to provide a single batch record with an intuitive review and approval interface. With GMP compliance and tracking at its core, the MODA-ES TM Platform ... Sartorius Stedim Biotech has announced the launch of the BIOSTAT RM TX single-use bioreactor. The unit, the company said, is a new mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies.

[Get More]
Sartorius | Posts - ResearchGate

Sartorius | Posts - ResearchGate

BioProcess Online bioanalytics, bioreactors,bioprocess sensors, cell culture media,immunochemicals, chromatography, cell culture media, biopharm contract manufacturing End-to-end, GMP Production Platform for Synthon’s Biologics Pipeline "The engineering principles represented in the Sartorius bioreactor portfolio were essential in the smooth scale-up of cell culture from lab scale to a disposable 2000L reactor.

[Get More]
End-to-end, GMP Production Platform for Synthon’s ...

End-to-end, GMP Production Platform for Synthon’s ...

News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream/downstream processing, cell culture and regulations Sartorius Stedim Biotech (SSB), a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Imm Sartorius and Immunochina Partner to Advance ...

[Get More]
Cytiva | Cytiva, formerly GE Healthcare Life Sciences

Cytiva | Cytiva, formerly GE Healthcare Life Sciences

When used, small scale models should be described and their relevance for the commercial scale should be justified, in terms of objective, design, inputs and outputs . When validation studies are highly dependent on the small scale model studies (e.g. design space claimed), it may be necessary to A Representative from Sartorius Stedim Biotech Adapting Cell Culture For Fed-batch and Perfusion Processes Spotlight Presentation A Representative from Sphere Fluidics (3:15) Spotlight Presentation A Representative from Genedata 15:30 Networking Refreshment Break 16:00 Cell Culture Process Controls, Novel Sensors and Real-Time Monitoring Methods

[Get More]
Continual Improvements Advance Continuous …

Continual Improvements Advance Continuous …

During the past decade, single-use bioreactors have become widely accepted for use in cell culture process development and clinical manufacturing. Their key benefits over stainless steel bioreactors are flexibility, cost, and time savings associated with the reduction of cross-contamination risks (1). Here, we describe our approach to development and qualification of the Biostat STR single-use ... Sartorius Stedim Biotech supplies the widest range of cell culture bioreactors for research and development work through to pilot and cGMP Manufacture. Optimally suited for production of mAbs, vaccines, recombinant proteins and in cell and gene therapy applications, the systems support many different types of cell lines and processes including batch, fed-batch and perfusion | continuous ...

[Get More]
The Next Generation Electronic Batch Record | Lonza

The Next Generation Electronic Batch Record | Lonza

The biotherapeutic market has been rapidly adopting single-use technologies to reduce risk and improve operational efficiencies. Single-use technologies have been proven to be robust and scalable from lab/scale-up to cGMP production applications including, bioprocessing equipment and automation, flexible containment, and rigid containment product portfolios. BioProcess International magazine covers the whole bioprocessing industry: biotherapeutic process and product development and biomanufacturing.

[Get More]
Guideline on process validation for the manufacture of ...

Guideline on process validation for the manufacture of ...

Bioreactor design and engineering are important to cell and protein production, particularly in performance and scale-up considerations. Lye discussed key factors for engineering characterization: the Reynolds number for determining fluid flow (with systems ideally being in the turbulent region), power input, oxygen mass transfer, and shear. WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing.

[Get More]
Sartorius launches GMP platform BIOSTAT RM TX single …

Sartorius launches GMP platform BIOSTAT RM TX single …

Cytiva is a provider of leading life sciences brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman. Cell culture removed from the bioreactor via separation pump and delivered to centrifuge insert; pinch valves are closed. Centrifuge concentrates the cells over a set time period. Upon completion, the separation pump is turned off, and the pinch valves adjusted to that the concentrated cells are returned to the bioreactor.

[Get More]
Cell Therapy Production Moves to Factory Floor

Cell Therapy Production Moves to Factory Floor

Pall provides complete biotech coverage from cell culture to formulation and filling. Our biotech portfolio helps create life improving drugs faster and with lower upfront costs. Just like the biotech industry, Pall continues to innovate. For example, our continuous processing technologies enable truly continuous production steps. End-to-end, GMP Production Platform for Synthon’s Biologics Pipeline Key Achievements ... “The engineering principles represented in the Sartorius bioreactor portfolio were essential in the smooth scale-up of cell culture from lab scale to a disposable 2000L reactor.

[Get More]
Smart Continuous GMP Manufacturing - BioTech 2016

Smart Continuous GMP Manufacturing - BioTech 2016

End-To-End, GMP Production Platform For Synthon's Biologics Pipeline Increase Speed To Clinic Of New Biopharmaceuticals In Upstream Processing Reducing Upstream Processing Scale-Up Risks Using QbD Sartorius Stedim Biotech Presents Sartocon® Slice 50 ECO End-To-End, GMP Production Platform For Synthon's Biologics Pipeline. Source: Sartorius Stedim Biotech “The engineering principles represented in the Sartorius bioreactor portfolio were essential in the smooth scale-up of cell culture from lab scale to a disposable 2000L reactor.

[Get More]
Pharmaceutical Archives | EU GMP Consulting and Robotic ...

Pharmaceutical Archives | EU GMP Consulting and Robotic ...

The Biostat® RM (Rocking Motion), is a fully GMP compliant, wave-mixed bioreactor. It is used with single-use Flexsafe® RM bags which are proven for a broad range of different cell lines incl. CHO, NS0, SF9, E.coli, stem cells and CAR-T cells.  · Traditional fed-batch cell culture process as well as perfusion processes can be easily implemented in single-use systems. WuXi Biologics, an open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec company, has embraced single-use technologies at full steam since 2010.

[Get More]
Case Study End-to-end, GMP Production Platform for Synthon ...

Case Study End-to-end, GMP Production Platform for Synthon ...

Sartorius is excited to announce publication of the third edition of our Live-Cell Analysis Handbook, a popular publication for a broad range of scientists who perform cell biology assays as part ... Cell therapy products need to be mass produced. Fortunately, assembly lines are forming, and they’re preparing to churn out safe, reliable, and affordable constructs.

[Get More]
Biostat® RM - Wave-Mixed Bioreactor | Sartorius

Biostat® RM - Wave-Mixed Bioreactor | Sartorius

Cumulative experiences of mammalian and microbial GMP manufacturing production in compliant with local and global regulatory guideline. GMP manufacturing service in 200Lscale of microbial fermentation and 2000L scale of mammalian culture. We also provide GMP cell banking service for both microbial and mammalian. Highly skilled scientific roles could move elsewhere if the situation is not addressed as a matter of urgency. The Association of the British pharmaceutical industry, ABPI, has released “Bridging the skills gap in the biopharmaceutical industry (2019)”, its latest survey looking at the challenges of recruiting suitably qualified and experienced staff.

[Get More]